[Accepted Manuscript] Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.

Manchanda, R.; Patel, S.; Gordeev, V.S.; Antoniou, A.C.; Smith, S.; Lee, A.; Hopper, J.L.; MacInnis, R.J.; Turnbull, C.; Ramus, S.J.; +5 more... Gayther, S.A.; Pharoah, P.D.P.; Menon, U.; Jacobs, I.; Legood, R.; (2018) [Accepted Manuscript] Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women. Journal of the National Cancer Institute. ISSN 0027-8874 DOI: https://doi.org/10.1093/jnci/djx265

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/jnci/djx265

Abstract

Share

Download

Embargo Date: 18 January 2019

Restricted to: Repository staff only

Request a copy

Filename: Cost-effectiveness of population_GREEN AAM.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

[img]

Downloads

View details

Metrics & Citations


Google Scholar